NCT03877926Phase 3Completed

VELOCITY: An Anthrax Vaccine Clinical Study

Study sponsor: Emergent BioSolutions

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-08-06Actual
Enrollment · participants3689Actual
Source updated2026-05-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Actual enrollment decreased by 173 participants

Before: 3862 participants (actual). After: 3689 participants (actual).

Check registry source